An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated low density lipo-protein.
Advanced glycation end products (AGEs) are thought to contribute to the abnormal lipoprotein profiles and increased risk of cardiovascular disease in patients with diabetes and renal failure. D-ribose is one of the naturally occurring pentose monosaccharide present in all living cells and is a key component of numerous biomolecules involved in many important metabolic pathways. Formation of D-ribose derived glycated low density lipoprotein (LDL) has been previously demonstrated but no studies have been performed to assess the immune complex deposition in the kidney of rabbits immunized with glycated LDL. In this study, LDL was glycated with D-ribose, and it was further used as an immunogen for immunizing NZW female rabbits. The results showed that female rabbits immunized with D-ribose modified LDL induced antibodies as detected by direct binding and competitive ELISA. The modified LDL was found to be highly immunogenic eliciting high titer immunogen-specific antibodies, while the native forms were moderately immunogenic. The induced antibodies from modified LDL exhibited wide range of heterogeneity in recognizing various proteins and amino acids conformers. Furthermore, our histopathological results illustrated the deposits of immune complex in glomerular basement membrane in rabbits immunized with D-ribose-LDL.
Department of Bio-Engineering, Integral University, Lucknow, India; Department of Bio-Sciences, Integral University, Lucknow, India.
Firoz
F
Akhter
Department of Bio-Sciences, Integral University, Lucknow, India.
M Salman
MS
Khan
Department Toxicology, Central Drug Research Institute (CDRI), Lucknow, India.
Sarika
S
Singh
Department of Bio-Sciences, Integral University, Lucknow, India.
Saheem
S
Ahmad
D000818:Animals; D000936:Antigen-Antibody Complex / Q000276:immunology*; D005260:Female; D050533:Glomerular Basement Membrane / Q000276:immunology* / Q000473:pathology; D017127:Glycation End Products, Advanced / Q000276:immunology*; D007105:Immune Complex Diseases / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology; D008077:Lipoproteins, LDL / Q000276:immunology*; D011817:Rabbits; D012266:Ribose / Q000276:immunology*
D000936:Antigen-Antibody Complex; D017127:Glycation End Products, Advanced; D008077:Lipoproteins, LDL; D012266:Ribose